Implantation or Injectable Dosage Form New Animal Drugs; Amikacin Sulfate Injection

الملخص

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an abbreviated new animal drug application (ANADA) filed by Phoenix Scientific, Inc. The ANADA provides for the use of amikacin sulfate injection for the treatment of the following conditions in dogs: genitourinary tract infections (cystitis) caused by susceptible strains of Escherichia coli and Proteus spp. and skin and soft tissue infections caused by susceptible strains of Pseudomonas spp. and E. coli.